- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06673147
Effects of Nordic Walking on Prenatal Health (Nordic Walking)
July 7, 2025 updated by: Wafaa Mahmoud Amin, University of Jazan
Effects of Nordic Walking on Prenatal Health: A Focus on Gait Kinematics, Musculoskeletal Pain, and Quality of Life. A Randomized Controlled Trial.
This randomized controlled trial (RCT) aimed to evaluate the effects of Nordic walking (NW) on gait kinematics, musculoskeletal pain, and quality of life in pregnant women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Healthy pregnant women (N=50), aged 20-40 years and between 13 and 28 weeks of gestation, experiencing mild to moderate musculoskeletal pain, will be recruited.
Participants will be randomized into either an intervention group (NW training) or a control group receiving standard prenatal care.
The intervention group will undergo a 4-week learning phase followed by an 8-week NW program (3 sessions per week, 45 minutes per session), led by a certified instructor.
Outcome measures will be assessed at baseline, after 4 weeks, and post-intervention (8 weeks), including spatiotemporal gait parameters (will be assessed using the GAITRite system), musculoskeletal pain (will be measured via Visual Analog Scale, VAS), and quality of life (will be measured using the SF-36 Health Survey).
Study Type
Interventional
Enrollment (Actual)
55
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alkharj
-
Riyadh, Alkharj, Saudi Arabia, 11942
- Department of Health and Rehabilitation Sciences, Prince Sattam bin Abdulaziz University.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Healthy women aged 20 to 40 between 13 and 28 weeks into singleton pregnancy.
- Participants must be experiencing mild to moderate musculoskeletal discomfort, such as lower back or pelvic pain,
- Participants have no prior musculoskeletal or neurological diseases.
- They must have no contraindications to exercising throughout pregnancy, as established by obstetrician clearance, and be able to engage in moderate physical activity under medical recommendations
Exclusion Criteria:
- History of diseases affecting bony structures or lumbar intervertebral discs.
- Pain caused by non-musculoskeletal factors (such as urinary tract infections or obstetric complications).
- Multiple pregnancies, pre-existing mobility conditions, and high-risk pregnancies or complications that restrict physical activity.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
It will be receiving Nordic walking training
|
Traditional Nordic walking poles will be modified according to International Nordic Walking Federation guidelines, which meant that the elbows were bent at a 90°angle when holding the poles in a vertical position.
Nordic Walking will be conducted in two phases consisting of a 4-week learning phase followed by an 8-week main phase of intervention.
|
|
No Intervention: Control Group
This group will receive a standard prenatal care, which included routine obstetric check-ups and general advice on physical activity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spatial gait parameters
Time Frame: 20 minutes
|
A GAITRite system will be used to assess the spatial parameters of gait
|
20 minutes
|
|
Temporal parameters of gait
Time Frame: 20 minutes
|
A GAITRite system will be used to assess the temporal parameters of gait
|
20 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Score for musculoskeletal pain
Time Frame: 5 minutes
|
The Visual Analog Score is depicted as a 10 cm horizontal line divided into 1 cm sections, each representing 1 point, resulting in a score ranging from 0 to 10 points.
Higher scores mean worse outcome.
|
5 minutes
|
|
Quality of life
Time Frame: 10 minutes
|
The SF-36 Health Survey will be used to determine the results.
|
10 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Nadia L Radwan, PHD, Prince Sattam Bin Abdulaziz University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 5, 2024
Primary Completion (Actual)
May 6, 2025
Study Completion (Actual)
June 29, 2025
Study Registration Dates
First Submitted
November 1, 2024
First Submitted That Met QC Criteria
November 1, 2024
First Posted (Actual)
November 4, 2024
Study Record Updates
Last Update Posted (Estimated)
July 8, 2025
Last Update Submitted That Met QC Criteria
July 7, 2025
Last Verified
November 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RHPT/024/016 (Other Identifier: Prince Sattam bin Abdulaziz University)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Walking
-
Giresun UniversityCompletedToe Walking Behaviors | Backward WalkingTurkey
-
Bai XiaorongActive, not recruiting
-
Taipei Medical UniversityNot yet recruitingWalking Intervention
-
Sheba Medical CenterUnknown
-
University of OxfordBritish Society for Children's Orthopaedic SurgeryRecruiting
-
ElsanEuropean Clinical Trial Experts NetworkCompletedCOPD | Walking PerformanceFrance
-
Mayo ClinicCompleted
-
Karolinska InstitutetCompleted
-
University of British ColumbiaCompletedIdiopathic Toe WalkingCanada
-
Chang Gung Memorial HospitalCompleted
Clinical Trials on Prenatal Nordic Walking
-
Federal University of Rio Grande do SulHospital de Clinicas de Porto Alegre; Federal University of Health Science...CompletedParkinson Disease | Parkinson Disease 10Brazil
-
Azienda Ospedaliera Universitaria Integrata VeronaUniversita di VeronaUnknownHypertension | Metabolic Syndrome | Overweight and Obesity | Cardiovascular Risk Factor | Sarcopenic Obesity | Disability Physical | Abdominal ObesityItaly
-
Human Locomotion ScienceUniversity of Southern Denmark; National Board of Health, Denmark; Nordic Institute... and other collaboratorsUnknown
-
Je Bouge Pour Mon MoralUniversity Grenoble AlpsCompletedDepressive SymptomsFrance
-
Ottawa Heart Institute Research CorporationCompleted
-
Federal University of Rio Grande do SulCompleted
-
University of SaskatchewanSaskatchewan Health Research Foundation; Royal University Hospital Foundation; Saskatchewan Centre for Patient-Oriented ResearchCompletedOsteoporosis | Vertebral Fracture | HyperkyphosisCanada
-
University of Ontario Institute of TechnologyLakeridge Health Corporation; Southlake Regional Health CentreCompletedNeoplasms | Cancer
-
University of TalcaNot yet recruiting
-
Grand Valley State UniversityCompletedParkinson DiseaseUnited States